Pediatrix Medical Group, Inc. (MD) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1157434,
    "name": "Pediatrix Medical Group, Inc.",
    "stock_name": "Pediatrix Medical Group, Inc.",
    "full_name": "Pediatrix Medical Group, Inc.",
    "name_url": "stocks-analysis/pediatrix-medical-group-inc",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "22.29",
    "chg": -1,
    "chgp": "-4.29%",
    "dir": -1,
    "prev_price": "23.29",
    "mcapval": "1,476.08",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 3365,
    "indexname": "S&P 500",
    "isin": "US58502B1061",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "3.21 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pediatrix-medical-group-inc-1157434-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Pediatrix Medical Group Hits New 52-Week High of $22.38",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pediatrix-medical-group-hits-new-52-week-high-of-2238-3674041",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PediatrixMedica_priceRelatedfactors_3674041.png",
        "date": "2025-11-05 16:46:47",
        "description": "Pediatrix Medical Group, Inc. achieved a new 52-week high, reflecting its strong performance in the Pharmaceuticals & Biotechnology sector with significant growth over the past year. The company boasts a market capitalization of USD 1,476 million, a favorable P/E ratio, and robust operational metrics, indicating solid financial health."
      },
      {
        "title": "Pediatrix Medical Group Hits Day High with 24.22% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pediatrix-medical-group-hits-day-high-with-2422-surge-in-stock-price-3671575",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PediatrixMedica_priceRelatedfactors_3671575.png",
        "date": "2025-11-04 18:29:42",
        "description": "Pediatrix Medical Group, Inc. has shown strong performance, achieving a notable gain and reaching an intraday high. Over the past year, it has significantly outperformed the S&P 500. The company boasts a solid market capitalization, efficient management metrics, and robust financial health, indicating its strong position in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Pediatrix Medical Group Hits New 52-Week High of $21.24",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pediatrix-medical-group-hits-new-52-week-high-of-2124-3671519",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PediatrixMedica_priceRelatedfactors_3671519.png",
        "date": "2025-11-04 17:57:30",
        "description": "Pediatrix Medical Group, Inc. achieved a new 52-week high, reflecting its strong performance in the Pharmaceuticals & Biotechnology sector. With a market cap of USD 1,476 million, the company boasts impressive financial metrics, including a favorable P/E ratio, solid return on equity, and robust operating cash flow."
      },
      {
        "title": "Pediatrix Medical Group Achieves Strong Valuation Metrics Amid Impressive Growth Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pediatrix-medical-group-receives-upgrade-to-buy-from-marketsmojo-amid-strong-financial-metrics-3640229",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/PediatrixMedica_mojoScore_3640229.png",
        "date": "2025-10-23 15:48:57",
        "description": "Pediatrix Medical Group, Inc. has recently experienced a valuation adjustment, reflecting a favorable assessment of its financial health. Key indicators include a competitive P/E ratio of 8, strong operational efficiency with a ROCE of 16.57%, and impressive profit growth of 44.5% over the past year."
      },
      {
        "title": "Is Pediatrix Medical Group, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-pediatrix-medical-group-inc-overvalued-or-undervalued-3637831",
        "imagepath": "",
        "date": "2025-10-21 12:09:48",
        "description": "As of 17 October 2025, the valuation grade for Pediatrix Medical Group, Inc. has moved from attractive to very attractive, indicating a positive shift in its perceived value. Based on the current metrics, the company appears to be undervalued. Key ratios include a P/E ratio of 8, an EV to EBITDA of 7.17, and a PEG ratio of 0.19, all of which suggest that the stock is trading at a discount compared to its earnings growth potential.\n\nIn comparison to peers, Pediatrix Medical Group has a lower P/E ratio than Hims & Hers Health, Inc., which stands at 54.76, and a more favorable EV to EBITDA ratio than RadNet, Inc., which is at 26.07. This further reinforces the notion that Pediatrix is undervalued relative to its industry peers. Additionally, the company's stock has outperformed the S&P 500 across multiple periods, with a year-to-date return of 25.38% compared to the S&P 500's 13.30%, highlighting its strong pe..."
      },
      {
        "title": "Pediatrix Medical Group, Inc. Experiences Revision in Its Stock Evaluation Amid Strong Market Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pediatrix-medical-groups-valuation-grade-upgraded-to-very-attractive-amid-strong-performance-3640794",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/PediatrixMedica_valuationdot_3640794.png",
        "date": "2025-10-20 16:31:01",
        "description": "Pediatrix Medical Group, Inc. has recently adjusted its valuation, showcasing strong financial metrics such as a P/E ratio of 8 and a PEG ratio of 0.19. The company has demonstrated resilience with a ROCE of 16.57% and a ROE of 19.10%, outperforming the S&P 500 over the past year."
      },
      {
        "title": "Is Pediatrix Medical Group, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-pediatrix-medical-group-inc-overvalued-or-undervalued-3634700",
        "imagepath": "",
        "date": "2025-10-20 12:27:08",
        "description": "As of 17 October 2025, the valuation grade for Pediatrix Medical Group, Inc. moved from attractive to very attractive, indicating a strong positive outlook. The company is currently undervalued, supported by a P/E ratio of 8, an EV to EBITDA of 7.17, and a PEG ratio of 0.19, all of which suggest that the stock is trading at a significant discount relative to its earnings growth potential. In comparison, Hims & Hers Health, Inc. has a much higher P/E ratio of 54.76, while Addus HomeCare Corp. is at 22.05, highlighting Pediatrix's relative value in the market.\n\nRecent performance shows that Pediatrix Medical Group has outperformed the S&P 500, with a year-to-date return of 25.38% compared to the S&P 500's 13.30%. This strong performance, coupled with its attractive valuation ratios, reinforces the conclusion that the stock is undervalued in the current market environment...."
      },
      {
        "title": "Is Pediatrix Medical Group, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-pediatrix-medical-group-inc-overvalued-or-undervalued-3632236",
        "imagepath": "",
        "date": "2025-10-19 12:04:38",
        "description": "As of 17 October 2025, the valuation grade for Pediatrix Medical Group, Inc. moved from attractive to very attractive, indicating a positive shift in its valuation outlook. The company appears undervalued, supported by a P/E ratio of 8, a PEG ratio of 0.19, and an EV to EBITDA ratio of 7.17. In comparison to peers, Hims & Hers Health, Inc. has a significantly higher P/E ratio of 54.76, while Addus HomeCare Corp. shows a fair valuation with a P/E of 22.05.\n\nPediatrix Medical Group has demonstrated strong returns, with a year-to-date return of 25.38% compared to the S&P 500's 13.30%, reinforcing its attractive valuation story. Additionally, the company's ROE stands at 19.10%, further highlighting its efficient use of equity...."
      },
      {
        "title": "Pediatrix Medical Group Hits New 52-Week High of $18.21",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pediatrix-medical-group-hits-new-52-week-high-of-1821-3604353",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/PediatrixMedica_priceRelatedfactors_3604353.png",
        "date": "2025-10-08 16:51:39",
        "description": "Pediatrix Medical Group, Inc. achieved a new 52-week high of USD 18.21 on October 7, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. With a market cap of USD 1,476 million, the company showcases solid financial metrics, including a P/E ratio of 8.00 and a return on equity of 18.01%."
      }
    ],
    "total": 16,
    "sid": "1157434",
    "stock_news_url": "https://www.marketsmojo.com/news/pediatrix-medical-group-inc-1157434"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Pediatrix Medical Group Hits New 52-Week High of $22.38

2025-11-05 16:46:47

Pediatrix Medical Group, Inc. achieved a new 52-week high, reflecting its strong performance in the Pharmaceuticals & Biotechnology sector with significant growth over the past year. The company boasts a market capitalization of USD 1,476 million, a favorable P/E ratio, and robust operational metrics, indicating solid financial health.

Pediatrix Medical Group Hits Day High with 24.22% Surge in Stock Price

2025-11-04 18:29:42

Pediatrix Medical Group, Inc. has shown strong performance, achieving a notable gain and reaching an intraday high. Over the past year, it has significantly outperformed the S&P 500. The company boasts a solid market capitalization, efficient management metrics, and robust financial health, indicating its strong position in the Pharmaceuticals & Biotechnology sector.

Pediatrix Medical Group Hits New 52-Week High of $21.24

2025-11-04 17:57:30

Pediatrix Medical Group, Inc. achieved a new 52-week high, reflecting its strong performance in the Pharmaceuticals & Biotechnology sector. With a market cap of USD 1,476 million, the company boasts impressive financial metrics, including a favorable P/E ratio, solid return on equity, and robust operating cash flow.

Pediatrix Medical Group Achieves Strong Valuation Metrics Amid Impressive Growth Performance

2025-10-23 15:48:57

Pediatrix Medical Group, Inc. has recently experienced a valuation adjustment, reflecting a favorable assessment of its financial health. Key indicators include a competitive P/E ratio of 8, strong operational efficiency with a ROCE of 16.57%, and impressive profit growth of 44.5% over the past year.

Is Pediatrix Medical Group, Inc. overvalued or undervalued?

2025-10-21 12:09:48

As of 17 October 2025, the valuation grade for Pediatrix Medical Group, Inc. has moved from attractive to very attractive, indicating a positive shift in its perceived value. Based on the current metrics, the company appears to be undervalued. Key ratios include a P/E ratio of 8, an EV to EBITDA of 7.17, and a PEG ratio of 0.19, all of which suggest that the stock is trading at a discount compared to its earnings growth potential. In comparison to peers, Pediatrix Medical Group has a lower P/E ratio than Hims & Hers Health, Inc., which stands at 54.76, and a more favorable EV to EBITDA ratio than RadNet, Inc., which is at 26.07. This further reinforces the notion that Pediatrix is undervalued relative to its industry peers. Additionally, the company's stock has outperformed the S&P 500 across multiple periods, with a year-to-date return of 25.38% compared to the S&P 500's 13.30%, highlighting its strong pe...

Pediatrix Medical Group, Inc. Experiences Revision in Its Stock Evaluation Amid Strong Market Metrics

2025-10-20 16:31:01

Pediatrix Medical Group, Inc. has recently adjusted its valuation, showcasing strong financial metrics such as a P/E ratio of 8 and a PEG ratio of 0.19. The company has demonstrated resilience with a ROCE of 16.57% and a ROE of 19.10%, outperforming the S&P 500 over the past year.

Is Pediatrix Medical Group, Inc. overvalued or undervalued?

2025-10-20 12:27:08

As of 17 October 2025, the valuation grade for Pediatrix Medical Group, Inc. moved from attractive to very attractive, indicating a strong positive outlook. The company is currently undervalued, supported by a P/E ratio of 8, an EV to EBITDA of 7.17, and a PEG ratio of 0.19, all of which suggest that the stock is trading at a significant discount relative to its earnings growth potential. In comparison, Hims & Hers Health, Inc. has a much higher P/E ratio of 54.76, while Addus HomeCare Corp. is at 22.05, highlighting Pediatrix's relative value in the market. Recent performance shows that Pediatrix Medical Group has outperformed the S&P 500, with a year-to-date return of 25.38% compared to the S&P 500's 13.30%. This strong performance, coupled with its attractive valuation ratios, reinforces the conclusion that the stock is undervalued in the current market environment....

Is Pediatrix Medical Group, Inc. overvalued or undervalued?

2025-10-19 12:04:38

As of 17 October 2025, the valuation grade for Pediatrix Medical Group, Inc. moved from attractive to very attractive, indicating a positive shift in its valuation outlook. The company appears undervalued, supported by a P/E ratio of 8, a PEG ratio of 0.19, and an EV to EBITDA ratio of 7.17. In comparison to peers, Hims & Hers Health, Inc. has a significantly higher P/E ratio of 54.76, while Addus HomeCare Corp. shows a fair valuation with a P/E of 22.05. Pediatrix Medical Group has demonstrated strong returns, with a year-to-date return of 25.38% compared to the S&P 500's 13.30%, reinforcing its attractive valuation story. Additionally, the company's ROE stands at 19.10%, further highlighting its efficient use of equity....

Pediatrix Medical Group Hits New 52-Week High of $18.21

2025-10-08 16:51:39

Pediatrix Medical Group, Inc. achieved a new 52-week high of USD 18.21 on October 7, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. With a market cap of USD 1,476 million, the company showcases solid financial metrics, including a P/E ratio of 8.00 and a return on equity of 18.01%.

View All News